| 摘要 |
<p>The present invention relates to novel cannabinoid receptor modulators, in particular cannabinoid 1 (CB1) or cannabinoid 2 (CB2) receptor modulators, and uses thereof for treating diseases, conditions and/or disorders modulated by a cannabinoid receptor (such as pain, neurodegenative disorders, eating disorders, weight loss or control, and obesity).</p> |
| 申请人 |
GLENMARK PHARMACEUTICALS S.A. |
发明人 |
MUTHUPPALANTAPPAN, MEYYAPAN;SUKEERTHI, KUMAR;BALASUBRAMANIAN, GOPALAN;GULLAPALLI, SRINIVAS;JOSHI, NEELIMA, KHAIRATKAR;NARAYANAN, SHRIDHAR;KARNIK, PALLAVI, V. |
